See All Slides - tctmd.com

Slides

Presentation TCT 2012

When Should MVD be Managed Medically?

Presenter: William Boden

October 23, 2012

Presentation TCT 2012

TCT-87. Safety and Efficacy of the MitraClip for the Treatment of Patients with a Dilated Left Ventricle and Functional Mitral Regurgitation

Presenter: Anita Asgar

October 23, 2012

Presentation TCT 2012

Autologous Cardiac Stem Cells in VAD Patients

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

HFPEF: Overview of Pathophysiology and Therapies

Presenter: William Little

October 23, 2012

Presentation TCT 2012

TCT-37. Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in...

Presenter: Yoshinobu Onuma

October 23, 2012

Presentation TCT 2012

Surgical Perspectives of the MitraClip and Its Role in the Treatment of Severe Degenerative and Functional MR

Presenter: Hendrik Treede

October 23, 2012

Presentation TCT 2012

Pathogenesis of Vulnerable Plaque 2012: What's New?

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

Follow the (Lack of) Evidence: Medical Therapy and CRT!

Presenter: Allan Schwartz

October 23, 2012

Presentation TCT 2012

Abluminus (Envision Scientific) Program Update

Presenter: Sameer Dani

October 23, 2012

Presentation TCT 2012

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Presenter: Stefan Verheye

October 23, 2012

Advertisement

Slides

When Should MVD be Managed Medically?

TCT-87. Safety and Efficacy of the MitraClip for the Treatment of Patients with a Dilated Left Ventricle and Functional Mitral Regurgitation

Autologous Cardiac Stem Cells in VAD Patients

HFPEF: Overview of Pathophysiology and Therapies

TCT-37. Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in...

Surgical Perspectives of the MitraClip and Its Role in the Treatment of Severe Degenerative and Functional MR

Pathogenesis of Vulnerable Plaque 2012: What's New?

Follow the (Lack of) Evidence: Medical Therapy and CRT!

Abluminus (Envision Scientific) Program Update

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content